Suppr
超能文献

Dual antiplatelet therapy guided by platelet function testing.

作者信息

Angiolillo Dominick J

机构信息

University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA.

出版信息

Lancet. 2017 Oct 14;390(10104):1718-1720. doi: 10.1016/S0140-6736(17)32279-1. Epub 2017 Aug 28.

DOI:10.1016/S0140-6736(17)32279-1

PMID:28855079

Abstract

摘要

相似文献

Dual antiplatelet therapy guided by platelet function testing.

Lancet. 2017 Oct 14;390(10104):1718-1720. doi: 10.1016/S0140-6736(17)32279-1. Epub 2017 Aug 28.

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.

How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?

Int J Cardiol. 2018 Nov 15;271:28. doi: 10.1016/j.ijcard.2018.05.121.

A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.

Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.

Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

BMC Cardiovasc Disord. 2017 Jun 15;17(1):157. doi: 10.1186/s12872-017-0582-6.

Current Role of Platelet Function Testing in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.

Interv Cardiol Clin. 2017 Jan;6(1):151-166. doi: 10.1016/j.iccl.2016.08.011.

New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.

Clin Ther. 2013 Aug;35(8):1064-8. doi: 10.1016/j.clinthera.2013.07.429.

Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial.

J Thromb Thrombolysis. 2019 Apr;47(3):427-435. doi: 10.1007/s11239-019-01811-2.

Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.

EuroIntervention. 2019 Aug 9;15(6):e513-e521. doi: 10.4244/EIJ-D-18-01077.

Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002786. doi: 10.1161/CIRCINTERVENTIONS.115.002786.

引用本文的文献

Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.

Int J Mol Sci. 2024 Apr 3;25(7):3981. doi: 10.3390/ijms25073981.

Guided vs. conventional anti-platelet therapy for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.

Front Cardiovasc Med. 2023 Mar 21;10:1079332. doi: 10.3389/fcvm.2023.1079332. eCollection 2023.

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?

Front Cardiovasc Med. 2022 Aug 25;9:975969. doi: 10.3389/fcvm.2022.975969. eCollection 2022.

Antiplatelet therapy after percutaneous coronary intervention.

EuroIntervention. 2022 Apr 1;17(17):e1371-e1396. doi: 10.4244/EIJ-D-21-00904.

Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.

Expert Rev Clin Pharmacol. 2021 Aug;14(8):963-978. doi: 10.1080/17512433.2021.1927709. Epub 2021 May 26.

High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study.

Cardiovasc Diabetol. 2020 Oct 9;19(1):171. doi: 10.1186/s12933-020-01146-w.

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement.

J Thromb Thrombolysis. 2021 Jan;51(1):1-11. doi: 10.1007/s11239-020-02170-z.

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?

Eur Heart J Suppl. 2020 Jun;22(Suppl E):E132-E136. doi: 10.1093/eurheartj/suaa078. Epub 2020 Mar 29.

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.

JACC Basic Transl Sci. 2020 Mar 25;5(5):419-428. doi: 10.1016/j.jacbts.2020.02.009. eCollection 2020 May.

[Platelet GPⅠb-Ⅸ-Ⅴ receptor-mediated mechanism and its application in thrombotic diseases].

Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):532-536. doi: 10.3760/cma.j.issn.0253-2727.2019.06.017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Dual antiplatelet therapy guided by platelet function testing.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译